The companies Immunovant, Verdiva Bio, and Akero Therapeutics bagged the biggest biotech funding rounds overall in January ...

Amid the federal funding uncertainty for health and sciences, local life science leaders say this could be a moment for industry partners, investors and others to step up and support the sector.

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

During a panel discussion at this year’s Fierce JPM Week—which took place alongside the annual J.P. | This week on “The Top ...

Curie.Bio, the biotech accelerator and investment firm, has raised another $340 million to invest in startups.

Biotechnology venture capital is recovering from its slide and investors are expressing optimism about 2025, even as they ...

Global asset manager GordonMD Global Investments and South Korea’s biotech-focused venture capital firm Partners Investment have joined forces to launch a co-managed fund for biotech investments. The ...

North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...

The UK biotech sector raised £3.5bn in 2024, marking a 94% increase from the previous year, according to the BioIndustry ...

Biotech startup Exsure has raised Rs 3 crore in a funding round led by Unicorn India Ventures to advance its exosomal drug-delivery platform for anti-cancer treatments. The funds will support Exsure's ...

PFG Investments LLC owned 0.13% of Fortress Biotech worth $71,000 at the end of the most recent reporting period. Several other institutional investors and hedge funds have also bought and sold ...